Celgene Invests US$45 M in Quanticel in Cancer Collaboration with Buyout Option
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 11 (Table of Contents)
Published: 28 Nov-2011
DOI: 10.3833/pdr.v2011.i11.1617 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Celgene has formed a collaboration with Quanticel and its capital investor Versant Ventures that provides the start-up with an initial investment of US$45 M over 3...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS